Company Directory - Global Pharmaceutical Company
Company Details - Global Pharmaceutical Company
Global Pharmaceutical Company
WebsiteA leading global pharmaceutical company focused on developing innovative medicines and treatments.
CCI Score
CCI Score: Global Pharmaceutical Company
2.31
-0.01%
Latest Event
Pharmaceutical Lobbying Against TRIPS Waiver and Pandemic Agreement
The article details extensive lobbying by pharmaceutical companies and trade groups opposing the TRIPS waiver and influencing the WHO Pandemic Agreement negotiations. As a leading global pharmaceutical company, Global Pharmaceutical Company's practices are emblematic of an industry trend that hinders equitable access to essential medicines.
Take Action
So what can you do? Support by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
OBJECTOR
Global Pharmaceutical Company is currently rated as an Objector.
Latest Events
- OCT282024
The article details extensive lobbying by pharmaceutical companies and trade groups opposing the TRIPS waiver and influencing the WHO Pandemic Agreement negotiations. As a leading global pharmaceutical company, Global Pharmaceutical Company's practices are emblematic of an industry trend that hinders equitable access to essential medicines.
-75
Political Contributions and Lobbying Efforts
March 28
The report shows that pharmaceutical companies have been heavily involved in lobbying efforts to block the TRIPS waiver, which would facilitate timely and affordable access to critical medical tools. This aggressive political engagement favors corporate interests over public health, aligning with authoritarian practices by obstructing reform for global health equity.
Industry Lobbyists Work to Influence U.S. Position in Critical Global Health Negotiations
- OCT212024
A STAT analysis revealed that pharmaceutical executives, including those from Global Pharmaceutical Company, predominantly donated to Democratic candidates in the final stretch of the 2024 campaign, supporting progressive policies and reinforcing anti-fascist values.
+80
Political Contributions and Lobbying Efforts
March 28
The article highlights that executives from pharmaceutical firms have made individual contributions predominantly to Democratic candidates. This behavior supports progressive governance and helps counter authoritarian ideologies, reflecting a positive stance against far‐right influences.
Pharma execs donated more to Democrats in campaign’s final stretch
Alternatives
Kenilworth, United States
2.89
Basel, Switzerland
-19.75
Indianapolis, United States
-35.34
New Haven, USA
-38.83
Corporation
1.66
Corporation
1.00
Corporation
-12.13
Japan
26.16
Copenhagen, Denmark
2.36
Corporation
3.48
Industries
- 325411
- Medicinal and Botanical Manufacturing
- 325412
- Pharmaceutical Preparation Manufacturing
- 541712
- Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)
- 541711
- Research and Development in Biotechnology